Select Page
Responsive Centered YouTube Video
Innovative approach discussed for upper airway solutions in COVID-19 by international panel.
  • Introduction of panelists from various locations worldwide. 0:28

  • Sponsorship message highlighting research on COVID-19 autoimmunity and potential solutions. 4:35

  • Focus on nasal cycles and nasal inhalation delivery as strategies for COVID-19 prevention and treatment. 8:10

  • Discussion on candidate molecules like chromharynamine, xylitol, and grapefruit seed extract for nasal treatment. 14:06

  • Experimental evidence showing potential antiviral properties of these molecules in blocking virus entry into cells. 16:03

Innovative approach using cold air plasma to combat viral infections like COVID-19.
  • Cold air plasma device invented in 1967 shows promising results in treating colds and flu in Australia. 23:03

  • Plasma technology uses reactive oxygen and nitrogen to eliminate pathogens while protecting human cells. 25:04

  • Transdermal treatment with cold air plasma shows success in cases like diabetic foot and basal cell carcinoma. 27:05

  • Research on resonant frequencies and mechanical vibrations to inactivate viruses like COVID-19. 29:26

Importance of Nasal and Oral Hygiene in Addressing COVID-19 and the Neglected Therapies.
  • Nose and mouth play a crucial role in COVID-19 infection and transmission. 39:25

  • Basic nasal and oral hygiene is a simple yet effective approach often overlooked. 41:00

  • Encouragement for researchers to explore affordable and safe treatments. 41:21

  • 70,000 liters of air enter the nose and mouth daily, emphasizing their importance. 41:35

Innovative strategies for upper airway COVID-19 prevention and treatment discussed in a research presentation.
  • Povidone iodine shows promise as a low-cost, broad-spectrum antiviral for intercepting COVID-19 in the nasal and oral cavity. 41:56

  • Studies indicate significant reductions in death, hospitalization, and viral load with povidone iodine use. 45:02

  • Nasal and oral sprays of povidone iodine can be used multiple times a day for COVID-19 prevention and treatment. 50:00

  • High-risk populations, individuals with high exposure, and those hesitant to vaccinate could benefit from povidone iodine therapy. 50:13

  • Povidone iodine is affordable, with a cost of approximately a dollar per day for use. 51:44

Innovative strategies for COVID-19 in the upper airway discussed by panelists.
  • Jennifer Smith’s expertise in virology and vaccine development adds valuable perspective. 1:01:04

  • Chris Newton shares insights on parallels between chronic Lyme disease and long COVID. 1:03:07

  • Focus on prophylaxis and early intervention for COVID-19 to be effective. 1:04:29

  • John Abelis highlights the importance of intervening before symptoms develop. 1:05:04

  • Products like Cenotize and Tafix from Israel show promise in creating barriers in the nasal mucosa. 1:06:02

Innovative approaches for upper airway treatment and prophylaxis against COVID-19 discussed by experts.
  • Various molecules and interventions like dilute hydrogen peroxide and copper probes are being used for treatment and prophylaxis. 1:06:24

  • Nasal vaccination is underfunded but crucial for mucosal immunity and effective immune responses. 1:09:20

  • Delivery systems for intranasal vaccines need to consider particle size and deposition for optimal effectiveness. 1:10:03

  • Health status and mechanical barriers in the nasal passages can impact the efficacy of intranasal treatments. 1:12:04

  • Chlorpheniramine, while effective, requires attention to particle distribution for even protection. 1:15:19

  • Inhalation therapies like antihistamines and steroids show promise in addressing inflammation and immune dysregulation in COVID-19. 1:17:51

  • Focus on early-stage nasopharyngeal interventions and prophylaxis using hypertonic saline, hydrogen peroxide, and other agents. 1:19:04

Innovative upper airway treatment using non-equilibrium atmospheric pressure to combat pathogens like viruses.
  • Device emits reactive oxygen and nitrogen species to target pathogens like bacteria and viruses. 1:32:06

  • Operates at atmospheric pressure and temperature, producing oxygen singlet species for enhanced efficacy. 1:32:13

  • High voltage inside the device generates vortex-shaped emissions from needles for delivery. 1:32:45

Innovative approach using plasma technology for upper respiratory system treatment, showing promising results in preventing colds and flu.
  • Plasma technology clears upper respiratory system, leading to reduced colds and flu among patients. 1:32:51

  • No reported side effects from the gentle device that treats various illnesses safely. 1:34:34

  • Complex process involving high voltage, plasma generation, and controlled species reaching the human body. 1:37:06

  • Registered in Australia for treating and preventing colds and flu, potential for COVID-19 treatment after necessary studies. 1:43:10

Innovative upper airway strategies discussed in a meeting, including nasal cleansing and nasal sterilization.
  • Various interventions for upper airway protection were discussed. 1:45:24

  • Nasal cleansing and nasal sterilization may create natural resistance. 1:45:30

  • Market potential for products targeting vigilant individuals was mentioned. 1:46:36

  • Hypertonic saline solution with surfactants may reduce nasal congestion. 1:47:01

  • PVP-Iodine nasal spray showed rapid killing of COVID-19 virus. 1:50:03

  • Consideration for eye sterilization as an additional route of infection prevention. 1:51:02

  • Importance of utilizing multiple tools in managing COVID-19 for long-term battle. 1:54:02

  • Unique device with specialized engineering for upper airway protection. 1:57:02

Advancements in COVID-19 treatment, including oral therapies and timing of intervention, are crucial for better outcomes.
  • Variants of COVID-19 may require new vaccines with different spike proteins. 1:57:46

  • Oral antiviral agents like molnupiravir show promise in treating COVID-19. 1:59:02

  • Early intervention with existing oral medications like ivermectin and hydroxychloroquine can be effective. 2:04:01

  • Understanding the dual phase of COVID-19

  • viral replication and hyperinflammatory response

  • is crucial for treatment. 2:08:25

  • Therapy should be administered around days 5-8 to prevent progression to severe stages of the disease. 2:09:00

  • Recognition of different stages of COVID-19 and tailored treatment approaches are essential for successful outcomes. 2:10:07

  • Accessibility to affordable treatments, especially in low-income countries, remains a challenge. 2:11:23

Insights on future strategies for COVID-19 management and prevention.
  • Focus on developing affordable and accessible therapies for global use 2:11:30

  • Expectation of COVID-19 becoming endemic with sporadic outbreaks 2:11:49

  • Importance of early treatment and supportive care for COVID-19 patients 2:12:23

  • Emphasis on overall health and addressing health disparities 2:14:13

  • Concerns about evolving variants and global preparedness for future pandemics 2:15:59

  • Exploration of alternative vaccine strategies beyond spike proteins 2:19:05

  • Recognition of the importance of therapeutics over sole reliance on vaccines 2:22:45

  • Focus on understanding how COVID-19 evades the interferon response for effective prevention 2:23:02

Insights on potential mechanisms of immune response to COVID-19 and the role of vitamin D and vitamin C.
  • Mucosal vaccination may prevent virus replication in the body. 2:23:44

  • Stimulation of interferon in nasal passages may protect against infection with certain viruses. 2:23:57

  • Fear and panic surrounding COVID-19 have led to increased research and innovative approaches. 2:25:00

  • Potential autoimmune effects of COVID-19 and the formation of immune complexes are being investigated. 2:27:00

  • Vitamin D and vitamin C may play a role in immune response and reducing inflammation. 2:36:06

Engaging and insightful conversation on a relevant topic with active listener participation.
  • Conversation lasted over two and a half hours 2:37:19

  • Fascinating and interesting discussion 2:37:24

  • Consideration for a follow-up conversation 2:37:30

  • 75 people actively listening to the conversation 2:37:37

  • Acknowledgement and gratitude to participants 2:37:47

  • Positive wishes for the audience 2:37:54

  • Expression of learning and staying connected 2:38:00